En

June 12, 2020Newcastle, United Kingdom

Mastering Medicinal Chemistry VI is the latest in an ongoing series of conferences intended to provide expert advice and guidance to new practitioners in the field of drug discovery. It has been said that "there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems". 

Anticipating and preparing for such problems thus accelerates the delivery of new medicines: this event will feature presentations from experienced 'drug-hunters' in both industry and academia, who will talk about the challenges faced in modern drug discovery, and will share best practice common to all successful medicinal chemists.

Deadline for bursary application is April 28, 2020.

Deadline for abstract submission for poster presentation is May 20, 2020.

For more information please contact: cathy@cathyhillevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

June 24-26, 2020Madrid, Spain

Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.

This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation. 

Deadline for abstract submission is April 24, 2020.

For more information please contact: maggi@maggichurchouseevents.co.uk


Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)
  • Sociedad Española de Química Terapéutica (Spain)

July 1-3, 2020Bordeaux, France

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) is pleased to invite you to Bordeaux, France on July 1-3, 2020 for the 56th edition of the International Conference on Medicinal Chemistry (RICT 2020).

The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery".

As for previous editions of RICT, the scientific committee will ensure the high quality and diversity of the scientific programme together with the accessibility of the meeting to PhD/post-doc and local Master students. For the latter, an advantageous registration fee is proposed. Moreover, a special career session will be organised with industrial and academic participants.

In addition, a poster session will provide the opportunity for all participants to present their current results. “Best poster” prizes will be attributed at the end of the meeting.

For more information contact: secretariat@ldorganisation.com

Organised by:
  • Société de Chimie Thérapeutique (France)

September 21-23, 2020Verona, Italy

The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Evotec, Italy will support the eighth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

Deadline for abstract submission for oral communication is January 13, 2020.

Deadline for abstract submission for poster presentation is July 22, 2020.

Bursary application deadline is August 7, 2020.

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

September 20-24, 2020Barcelona, Spain

EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.

The program will include the following sessions:

  • QSAR without Borders
  • Artificial Intelligence in Drug Design
  • Molecular Dynamics and Kinetics
  • Chemical Space Annotation and Expansion
  • Modelling Drug Safety
  • Challenges in GPCR Drug Design
  • Modelling Drug Transport Mechanisms
  • Predicting Off-Target Pharmacology
  • Network Medicine
  • New Modes of Target Interaction
  • New Trends in Quantum Mechanics
  • Future Challenges Ahead

The 23rd EuroQSAR Symposium, entitled “Integrative Data-Intensive Approaches to Drug Design”, is organised on behalf of QCMS and is chaired by Jordi Mestres (IMIM Hospital del Mar Medical Research Institute).

Deadline for early bird registration and abstract submission for Oral Communications: June 11, 2020

Deadline for abstract submission for Poster Presentation: Auguste 4, 2020

For more information contact: secretariat@ldorganisation.com

October 26-27, 2020Eindhoven, The Netherlands

The Conference topics will include:

  • G-protein coupled receptors
  • Protein-protein interactions
  • Activity-based protein profiling
  • Carbohydrates/glycans
  • Cellular chemistry
  • Bioorthogonal and bioconjugation chemistry
  • Fragment-based drug design
  • Photopharmacology
Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

November 5-7, 2020Athens, Greece

18th Hellenic Symposium on Medicinal Chemistry (HSMC-18) is organized by the Hellenic Society of Medicinal Chemistry (HSMC).

It continues the tradition of biannual meetings established since 35 years in Greece as a forum for the discussion of recent advances in medicinal chemistry. The topics include drug design and lead identification and optimization, protein-protein interactions and protein degradation, ADME/Tox properties, advances in Synthetic Medicinal Chemistry, Natural Products, Pharmacology as well as the impact of artificial intelligence in the integration of data-intensive practices to Drug Discovery. 

For more information please contact: s.si@zita-congress.gr

Organised by:
  • Hellenic Society of Medicinal Chemistry (Greece)

April 2021London, United Kingdom

Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This third meeting in the series will feature talks on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and other aspects of transporters relevant to drug discovery and development. 

For more information please contact: conferences@soci.org

Organised by:

SCI's Fine Chemicals Group, RSC’s Biological and Medicinal Chemistry Sector (BMCS) and the Drug Metabolism Discussion Group (DMDG)


May 4-5, 2021Liverpool, United Kingdom

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.

The event programme will incorporate sessions themed around the following key topics:
- DMPK and Drug Discovery
- DMPK and Drug Safety
- Analytical and Computational Advances in DMPK

In addition, the programme also includes a keynote talk, ‘flash’ presentations from early career researchers, and opportunities for open debate and discussion.

For more information please contact: maggi@maggichurchouseevents.co.uk

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)